Back to 
BlackRock Finance, Inc.
BlackRock Finance, Inc.
CRDF
Showing 0 of 3 quarters
Position history for BlackRock Finance, Inc.'s holdings in Cardiff Oncology, Inc.
As of its last 13F, for Q2 2024, BlackRock Finance held 2,628,407 shares of CRDF (Cardiff Oncology), worth $5.8M. It increased the position from 677,458 shares in Q1 2024. BlackRock Finance held CRDF from Q4 2023 to Q2 2024, across 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.